Position in ANIP
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$34,355,685
+$3,414,433 QoQ
Shares Held
415,024
+3.1% QoQ
Ownership
1.81%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#12
of 305 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIP Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Nuveen, LLC holds $1,256,235,792 across 44 Drug Manufacturers - Specialty & Generic names. ANIP ranks #14 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
15,332,859 | $143,055,573 | |
| 2 | ZTS |
Zoetis Inc.
|
1,799,647 | $129,322,632 | |
| 3 | ALKS |
Alkermes plc.
|
2,324,197 | $121,787,920 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,230,980 | $109,465,602 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
200,059 | $108,397,967 | |
| 6 | VTRS |
Viatris Inc
|
6,007,467 | $95,398,575 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
459,301 | $77,410,589 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
3,324,875 | $57,553,584 |
All Filings in ANIP
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,355,685 | 415,024 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $30,941,252 | 402,357 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $30,557,831 | 387,102 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $36,188,869 | 395,075 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $24,206,183 | 370,976 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $3,253,836 | 48,601 | Shares | Defined | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||